Issued On Behalf Of Sleepcogni

Sleepcogni Could Finally Signal The End Of Sleeping Pills

Visionary new health device offers hope for global insomnia epidemic

Monday 9 November sees the launch on Kickstarter of SleepCogni – a revolutionary new product designed to give insomniacs everywhere what they have been looking for –  a good night’s sleep induced naturally without the risk of drug dependancy1. Finally, SleepCogni offers an answer to sleep deprivation – something the Centre of Disease & Control (CDC) describes as a global health epidemic2.


Developed by award winning3 medical device inventor Richard Mills (in response to his own battles with sleepless nights), SleepCogni is a unique bedside sleep device that is backed by some very clever technology and supported by Sheffield Hallam University4 and international sleep expert and founder of the London Sleep Centre, Dr Irshaad Ebrahim.

“I became convinced it wasn’t just the hour before bed that explained why I couldn’t fall asleep, it was the whole modern lifestyle,” said SleepCogni inventor Richard Mills. “the stress and over-stimulus in daily life is contributing to the inability to fall sleep and stay asleep. SleepCogni has proved successful in clinical trials and endorsed by those who have seen it in action.”


The approach is so groundbreaking that when Dr Irshaad Ebrahim first met Richard, he gave SleepCogni his backing within minutes, while clinical studies of the pilot trial at Sheffield Hallam University confirmed SleepCogni is effective in treating patients with insomnia: 50% of those trialed reporting an improvement in quality of sleep and 40% reporting an increase in sleep duration, with the remainder of patients showing no change thus indicating a substantial improvement.


“I have been waiting for someone to come to me with something tangible that patients could use themselves to treat their insomnia,” said Dr Irshaad Ebrahim of the London Sleep Centre. “SleepCogni is an integrated piece of scientifically validated research based treatment for insomnia. With devices like SleepCogni I see a trend to provide the patient with the tools to treat their own insomnia rather than relying on seeing professionals and leaving only the more serious insomnia to be treated one-to-one”.


SleepCogni monitors heart rate, mental alertness, skin temperature and movement. It is a non-invasive, and as simple to use as pressing a button. Personalised to the user, SleepCogni interacts with the patient to produce a programme of audio, visual and tactile cues to help induce sleep. The device also trains the brain with its programmes, which means the more it’s used, the more effective it becomes.


We are all hyper-aroused and over-stimulated from the moment we awaken; triggering our ‘fight or flight’ mode. For many, winding down before bed involves films, phones, browsing the internet and devices that emit blue light are suppressing melatonin – delaying natural cues‎ to sleep. SleepCogni reverses the ill effects of all of this with a revolutionary technology that doesn’t stimulate. NASA have recently used the same LED technology on the international space station, which helps astronauts differentiate between day and night.


“SleepCogni is providing a means to switch off today’s busy active minds, by combining environmental and personal data into an interactive sensory experience and the gold standard insomnia treatment,” added Richard. “It’s a modern means of counting sheep and clinically proven to help.”

SleepCogni is available on Kickstarter from Tuesday 10 November. The first 850 ‘early birds’ will receive the device for a 50% discounted price of £99 ($149) and delivered in June 2016. The device will go on sale to the wider public in September 2016.

The Kickstarter video can be viewed here: at the Kickstarter page:

To find out more, visit the website at  

Photograph & caption:
Photos of SleepCogni

Notes to Editors

  1. Facts about Sleeping Pills

15.3 million (£49.2M) National Health Service (NHS) prescriptions were handed out for sleeping pills in the UK 2012 compared with 14.5 million (£42M) in 2008, an increase of 17%. Patients can also suffer from more severe anxiety with panic attacks etc.

The trend is more towards prescribed drug based suppressants (sleeping tablets Z-tabs) that are both addictive, harmful and for short term use only. The alternative natural herbal therapies (melatonin tablets) are short-lived or not very effective.


By 1930 over a billion sleeping pills were estimated to be swallowed each year in the U.S. The brand names have changed, but the popularity has only increased. Today around 60 million prescriptions for

sleep aids are given out each year in the U.S., part of a $32-billion sleep industry. US dollar sales of prescription sleeping pills jumped 27% through last September says IMS Health.

Sepracor’s Lunesta, introduced last April, sales of the drug – the first sleep aid approved by the Food & Drug Administration for long-term use totaled $329 million through December with 3.5 million prescriptions written.

Sleeping pills, led by Ambien, rack up more than $2 billion a year in the US

  1. Centre of Disease & Control (CDC)

Our sleep problems are so bad that CDC refers to them as “a public health epidemic.”

  1. Awards

Richard Mills is a double-award winning medical device and technology innovator and won the prestigious title of national ‘medical Start-up’ in 2015 at

  1. Sheffield Hallam University

The Sleep Easy project – initial results of the Clinical trials at Sheffield Hallam University are very encouraging and further refinement is planned through the launch in November on Kickstarter.  This will be done by mapping both good and bad sleep data to help everybody improve their sleep quality through remote software updates. The data collection will be used to help develop the perfect algorithm which could help others with the same profile i.e. age, sex etc. Ideally the developers’ ultimate aim is to find the perfect wind-down routine that promotes the best quality night’s sleep. This will all be fed back through regular software updates.

  1. NASA

NASA will replace the orbiting lab’s fluorescent bulbs with an array of LEDs switching between blueish, whitish and reddish light, according to the time of day. This is due to take place in 2016.

About SleepCogni

SleepCogni comprises a team of 20 professionals including sleep clinicians, researchers, technologists and sound specialist:

  • Richard Mills of SleepCogni is a double-award winning medical device and technology innovator.  He won the prestigious title of national ‘medical Start-up’ in 2015 at with his previous company innovation Swellaway. This was backed by England captain Wayne Rooney. With over 20 years’ experience in leading medical, internet & technology companies he has been quoted at being one of the top 10 entrepreneurs in Yorkshire.


  • Martyn Ware, pioneer of the electronic 80’s synthpop music sound and member of the bands Human League and Heaven 17 who developed the sound element of SleepCogni. He has worked with Tina Turner, Terence Trent D’Arby, Chaka Khan and many others. His company has gone onto to pioneer some very exciting dimensional 3D AudioScape surround-sound projects.
  • Dr Irshaad.Ebrahim was the first NHS appointed Consultant Neuropsychiatrist of sleep and memory disorders in the UK based at the Sleep Disorders Centre St.Thomas’ Hospital. He set up the London Sleep Centre in 2001.

  • Dr Maan van de Werken is a chronobiologist, specialised in the effect of light on human behaviour and physiology. For her PhD at the University of Groningen, The Netherlands, Maan studied the effect of light in the morning on sleep inertia, differential light composition on performance and melatonin suppression and the 24-h regulation of stress hormone release and skin temperature.
  • Medilink Ltd is a business led private sector partnership dedicated to the growth and
    development of the Health Technology and related Life Sciences Industries. SleepCogni has been accepted as a member.
  • Spotify recently reported that around 12% album sales were sleep related. They have a revenue of 1 billion euros:

Media contact

Jon Gardner


DDI: + 44 (0) 114 275 6996
Mobile: + 44 (0) 7930 697773

Leave a Reply